Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | CCR1 | P32246 | 3/20 | 0.42 |
| ▸ | CCR5 | P51681 | 3/20 | 0.42 |
| ▸ | CCR8 | P51685 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | ALPG | P10696 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15977727 | 0.86 | PDK2 (0.47) | PDK2PRMT5WDR77DHODHNPY5R | |
| SCHEMBL15977575 | 0.86 | PDK2 (0.42) | PDK2KDM4ECCR1CCR5CCR8 | |
| SCHEMBL15977933 | 0.86 | PDK2 (0.43) | PDK2KDM4ECCR1CCR5CCR8 | |
| SCHEMBL15198747 | 0.83 | PDK2 (0.41) | PDK2KDM4ECCR1CCR5CCR8 | |
| SCHEMBL15977790 | 0.83 | PDK2 (0.39) | PDK2 | |
| SCHEMBL10300927 | 0.82 | PDK2 (0.40) | PDK2RAB9A | |
| SCHEMBL20736580 | 0.81 | PDK2 (0.43) | PDK2KDM4ECCR1CCR5CCR8 | |
| SCHEMBL10300960 | 0.81 | SMN1; SMN2 (0.53) | KDM4ECCR1CCR5CCR8TP53 | |
| SCHEMBL20737219 | 0.81 | PDK2 (0.40) | PDK2KDM4ECCR1CCR5CCR8 | |
| SCHEMBL15977860 | 0.81 | PDK2 (0.40) | PDK2KDM4ECCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
| US-9559311-B2 | Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| US-9559311-B2 | Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| US-20140239273-A1 | ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
| US-20140239273-A1 | ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | PIEZO1, TMEM109, SLC39A14 | PDK2 924/4885KDM4E 3416/4885CCR1 304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.